Home / Research projects / Lenalidomide and dexamethasone (RD) versus lenalidom#3BB6394
Share
Lenalidomide and dexamethasone (RD) versus lenalidom#3BB6394
Multicenter, randomized, controlled, phase III, three parallel arm study to determine the efficacy and safety of lenalidomide in combination with dexamethasone (RD) versus lenalidom#3BB6394
Project objectives
Primary objectives:
To evaluate the efficacy of the combination of RD compared with MMR and CPR in elderly patients with newly diagnosed symptomatic multiple myeloma
evaluate the efficacy of lenalidomide as maintenance therapy (combined with prednisone) after the induction phase
Secondary objectives:
evaluate the safety of RDa compared with MMR and CPR in patients with newly diagnosed symptomatic multiple myeloma
evaluate the safety of lenalidomide as maintenance therapy after the induction phase
Start and end date
29/11/2010 - finished
Project Manager
Prof. Giuseppe Avvisati
Coordinating institution of the project
University Division of Hematology, AOUS Giovanni Baptist of Turin, Turin
Other Institutions involved
Institutions belonging to the Italian Group of Adult Hematological Diseases (GIMEMA)
L'Università Campus Bio-Medico di Roma promotes integrated teaching and research structures, pursuing the good of the person as the main aim of its activities.
